SAXENA NISHANT C (Chief Business Officer) purchased 21.8% of their position (13.50K shares) of CORBUS PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market purchase worth $101.2K — a significant purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/3/2026ACC: 0001193125-26-255834
Officer· Chief Business Officer
Since May 2026
+13.50K
Net shares
Net buyer
$101.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
13.50K acquired
Non-Derivative Transactions2
Common Stock, par value $0.0001 per share
Direct
Shares
+4.50K
Price / share
$7.33
Trade value
$33K
% of position
7.3%
6/2/2026
61.80K→66.30K
Common Stock, par value $0.0001 per share
Direct
Shares
+9K
Price / share
$7.58
Trade value
$68.22K
% of position
13.6%
6/3/2026
66.30K→75.30K
Total
Net shares
+13.50K
Net value
$101.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 6/2/2026 | P · Purchase | +4.50K | $7.33 | $33K | 7.3% | 61.80K | 66.30K |
| Common Stock, par value $0.0001 per share Direct | 6/3/2026 | P · Purchase | +9K | $7.58 | $68.22K | 13.6% | 66.30K | 75.30K |
| Total | +13.50K | $101.22K | ||||||
Derivative Transactions0
No derivative transactions reported